2022 FDA approvals

被引：56

作者：

Mullard, Asher

机构：

来源：

关键词：

D O I：

10.1038/d41573-023-00001-3

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

The FDA approved 37 novel drugs in 2022, the fewest to pass regulatory scrutiny since 2016.

引用

页码：83 / 88

页数：6

共 50 条

[1] 2022 FDA approvals
Asher Mullard
[J]. Nature Reviews Drug Discovery, 2023, 22 : 83 - 88
[2] FDA Approvals of Biologics in 2022
Martins, Alexander C.
Albericio, Fernando
de la Torre, Beatriz G.
[J]. BIOMEDICINES, 2023, 11 (05)
[3] 2022 in review: FDA approvals of new medicines
Kinch, Michael S.
Kraft, Zachary
Schwartz, Tyler
[J]. DRUG DISCOVERY TODAY, 2023, 28 (08)
[4] FDA new drug approvals in Q3 2022
Amy Brown
[J]. Nature Reviews Drug Discovery, 2022, 21 : 788 - 788
[5] FDA new drug approvals in Q3 2022
Brown, Amy
[J]. NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (11) : 788 - 788
[6] FDA new drug approvals in Q1 2022
Urquhart, Lisa
[J]. NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (05) : 329 - 329
[7] FDA new drug approvals in Q2 2022
Lisa Urquhart
[J]. Nature Reviews Drug Discovery, 2022, 21 : 550 - 550
[8] FDA new drug approvals in Q1 2022
Lisa Urquhart
[J]. Nature Reviews Drug Discovery, 2022, 21 : 329 - 329
[9] FDA approvals
不详
[J]. AMERICAN FAMILY PHYSICIAN, 2003, 67 (12) : 2629 - 2629
[10] FDA approvals
不详
[J]. GERIATRICS, 2000, 55 (10) : 20 - 20